EXTENSIVE COMPANY/LOGO RECOGNITION
ESMO VIDEO SERIES 2026
The ESMO Video Series has been designed to deliver bitesize, cutting-edge, engaging content to keep our busy members up-to date with the lastest research, in a time effective manner. In 2026 ESMO will produce six tumour tracks, each available for multi-support.
6 TRACKS PER YEAR
MULTI-SPONSORED PER TRACK
BREAST CANCER
LUNG CANCER
GASTROINTESTINAL CANCERS
GENITOURINARY CANCERS
GYNAECOLOGICAL CANCERS
AI & DIGITAL ONCOLOGY
ABOUT ESMO VIDEO SERIES CONTENT
TYPES OF VIDEOS
BREAKING SCIENCE
Reporting on the latest developments from ESMO Congresses
INSIGHT
In-depth videos providing wider context and discussions
ESMO REVIEW
A comprehensive look at the year’s most impactful clinical trials and research advancements
EDUCATION
Addressing unmet needs for practicing oncologists
CONGRESS COVERAGE











VIDEO SERIES
Description. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et
Biliary Tract Tumours: ESMO Guideline Update
PRECISO MTB: NGS-Based Precision Oncology Programme via Liquid Biopsy in Thoracic Malignancies
Transcriptomic & Epigenomic Heterogeneity in High-Grade Serous Ovarian Cancer Under Chemo
ESMO Review: Upper GI Cancer
PARERE: Liquid biopsy-guided anti-EGFR re-treatment in RAS/BRAF wt chemorefractory mCRC
PANOVA-3: Pain and QoL outcomes with TTFields in LAPC
QS Ovar - AGO: Treatment and outcome of elderly patients with early ovarian cancer
BOUQUET: Novel regimens for persistent/recurrent rare EOC according to biomarker status
Urothelial Carcinoma: Evolving Sequence in Metastatic Urothelial Carcinoma
Renal Cell Carcinoma: Adjuvant: A One-Size-Fits-all Approach or Toward Patient Selection?
AI in Targeted Anticancer Therapy
OPTIMA prelim: Clinical Outcomes in EBC
Longitudinal Synthetic Data Generation by AI in Breast Cancer
Young BRCA Carriers: Safety of Subsequent Pregnancy
Episode 6: Skin Toxicity Induced by Targeted Therapy (Oncology)
HER2-targeted T-cell Engager for Advanced Solid Tumours
Show more
BENEFITS FOR OUR PARTNERS
WEBINAR HOSTED ON-DEMAND ON ONCOLOGYPRO FOR 2 YEARS
FULL OUTCOMES REPORT INCLUDING LIVE AND ON-DEMAND METRICS
SUPPORT OPTIONS
Support type |
Funding amount per sponsor (EUR) |
|---|---|
| Multi-sponsored | €30,000 per track for 1 year (standard rate) €25,000 per track for 1 year (OncologyPRO sponsor rate) |
ESMO VIDEO SERIES 2025 - STATISTICS
PARTICIPANTS
594
Countries & Territories
57
Oncology Clinicians
58.7%
Abstracts presented
121
Programme Speakers
66



Download the prospectus to find out about sponsorship and funding opportunities
SUPPORTERS OF THE ESMO VIDEO SERIES 2025










